Global /South Korea /Healthcare /Drug Manufacturers - Specialty & Generic /377220

From Bio Co.,Ltd

377220

• KRX: 377220 • Delayed

1,285KRW 0.1%

0.8383 USD

As of 6 June 2026, From Bio Co.,Ltd has a market cap of $23.44M USD, ranking #35981 globally and #2263 in South Korea. It ranks #3233 in the Healthcare sector, and #194 in the Drug Manufacturers - Specialty & Generic industry.

Global Rank

35981

Country Rank

2263

Sector Rank

3233

Industry Rank

194

Key Stats

Market Cap

$23.44MUSD

35.93B KRW

Enterprise Value

$43.81MUSD

67.16B KRW

Revenue (TTM)

$47.08MUSD

72.16B KRW

EBITDA (TTM)

-$10.83MUSD

-16.6B KRW

Net Income (TTM)

-$14.65MUSD

-22.46B KRW

EBITDA Margin

-23%

Profit Margin

-31%

PS Ratio

0.5

PB Ratio

1.4

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

140

Founded

2006

Website

frombio-company.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.1%	-1.5%	2.3%	-7.2%	-10%	4%	-40%	-65%	-92%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	377220 프롬바이오 ISIN: KR7377220009 Shares Out.: Shares Outstanding: 28.31M¹ Shares Float: 16.887M² TV: TradingView: KRX: 377220 SA: Stock Analysis: KRX: 377220 YF: Yahoo Finance: 377220.KS GF: Google Finance: KRX: 377220 BA: Barron's: 377220 MS: Morningstar: XKRX: 377220	1,285 KRW	TV: TradingView: KRX: 377220 SA: Stock Analysis: KRX: 377220 YF: Yahoo Finance: 377220.KS GF: Google Finance: KRX: 377220 BA: Barron's: 377220 MS: Morningstar: XKRX: 377220

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About From Bio Co.,Ltd

From Bio Co.,Ltd manufactures and sells health related products in South Korea. It offers health functional food, health beauty, and living health products. The company also provides cosmetic products under the Mastina and HYCL brands. In addition, it operates an online platform to retail its products. The company was founded in 2006 and is headquartered in Suwon-si, South Korea.

Similar Companies

Industry: Drug Manufacturers - Specialty & Generic (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Myung In Pharmaceutical LTD. KRX: 317450	$539.11M 826.36B KRW 2K%	8.4	South Korea
FutureChem Co.,Ltd KRX: 220100	$278.08M 426.25B KRW 1K%	-	South Korea
KOLMAR BNH Co.,Ltd. KRX: 200130	$218.56M 335.01B KRW 833%	-	South Korea
Kwang Dong Pharmaceutical Co., Ltd. KRX: 009290	$203.29M 311.61B KRW 767%	16.3	South Korea
NOVAREX Co.,Ltd. KRX: 194700	$167.22M 256.31B KRW 613%	7.4	South Korea
Kyung Dong Pharmaceutical Co., Ltd. KRX: 011040	$98.78M 151.41B KRW 321%	17.8	South Korea

Industry: Drug Manufacturers - Specialty & Generic (Global)

Name	Market Cap (USD) diff.	PE	Country
Teva Pharmaceutical Industries Ltd. TLV: TEVA	$37.66B 108.92B ILS 161K%	24.2	Israel
Revolution Medicines, Inc. NASDAQ: RVMD	$29.56B 126K%	-	United States
Zhejiang NHU Company Ltd. SHE: 002001	$15.86B 107.34B CNY 68K%	16.0	China
Cipla Ltd. NSE: CIPLA	$11.12B 1.06T INR 47K%	23.4	India
Lupin Ltd. NSE: LUPIN	$11.0B 1.05T INR 47K%	22.7	India
Haisco Pharmaceutical Group Co., Ltd. SHE: 002653	$9.1B 61.6B CNY 39K%	80.6	China

chevron_leftBack